Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin.
暂无分享,去创建一个
[1] Grigory Rodchenkov,et al. Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014. , 2014, Drug testing and analysis.
[2] J. Vine,et al. A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography. , 2014, Drug testing and analysis.
[3] V. Besada,et al. Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] M. Thevis,et al. Metabolism of growth hormone releasing peptides. , 2012, Analytical chemistry.
[5] M. Thevis,et al. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry , 2011, Analytical and bioanalytical chemistry.
[6] S. Kageyama,et al. Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects. , 2010, Drug testing and analysis.
[7] S. Kageyama,et al. Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.
[8] L. Anderson,et al. Physiology of ghrelin and related peptides. , 2005, Domestic animal endocrinology.
[9] E. Arvat,et al. Effects of GHRP-2 and Hexarelin, Two Synthetic GH-Releasing Peptides, on GH, Prolactin, ACTH and Cortisol Levels in Man. Comparison with the Effects of GHRH, TRH and hCRH , 1997, Peptides.
[10] T. Badger,et al. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. , 1997, The Journal of endocrinology.
[11] V. Lenaerts,et al. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. , 1994, The Journal of clinical endocrinology and metabolism.
[12] Y. Okimura,et al. Intranasal administration of His-D-Trp-Ala-Trp-D-Phe-LysNH2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-I levels in normal men. , 1991, Endocrinologia japonica.
[13] J. Segura,et al. Growth hormone secretagogues: out of competition , 2011, Analytical and Bioanalytical Chemistry.
[14] Johansen Nl,et al. Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption , 1998 .